Your browser doesn't support javascript.
loading
Benefit of Apabetalone on Plasma Proteins in Renal Disease.
Wasiak, Sylwia; Tsujikawa, Laura M; Halliday, Christopher; Stotz, Stephanie C; Gilham, Dean; Jahagirdar, Ravi; Kalantar-Zadeh, Kamyar; Robson, Richard; Sweeney, Michael; Johansson, Jan O; Wong, Norman C; Kulikowski, Ewelina.
Affiliation
  • Wasiak S; Resverlogix Corp, Calgary, Alberta, Canada.
  • Tsujikawa LM; Resverlogix Corp, Calgary, Alberta, Canada.
  • Halliday C; Resverlogix Corp, Calgary, Alberta, Canada.
  • Stotz SC; Resverlogix Corp, Calgary, Alberta, Canada.
  • Gilham D; Resverlogix Corp, Calgary, Alberta, Canada.
  • Jahagirdar R; Resverlogix Corp, Calgary, Alberta, Canada.
  • Kalantar-Zadeh K; University of California, Irvine School of Medicine, Orange, California, USA.
  • Robson R; Christchurch Clinical Studies Trust, Christchurch, New Zealand.
  • Sweeney M; Resverlogix Inc., San Francisco, California, USA.
  • Johansson JO; Resverlogix Inc., San Francisco, California, USA.
  • Wong NC; Resverlogix Corp, Calgary, Alberta, Canada.
  • Kulikowski E; Resverlogix Corp, Calgary, Alberta, Canada.
Kidney Int Rep ; 3(3): 711-721, 2018 May.
Article in En | MEDLINE | ID: mdl-29854980